Search clinical trials for: DC Vaccine

Total 13744 results

GlaxoSmithKline

Completed

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Tetanus | Diphtheria | Acellular Pertussis

United States
Russian Academy of Medical Sciences

Completed

Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection

Liver Diseases | Virus Diseases | Hepatitis | Hepatitis C, Chronic

Russian Federation
Shenzhen People's Hospital

Unknown

DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2

Cervical Intraepithelial Neoplasia

China
Shenzhen People's Hospital

Unknown

Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer

Carcinoma, Non-Small Cell Lung | Carcinoma, Small Cell Lung

China
MCM Vaccines B.V.
Merck Sharp & Dohme LLC; Sanofi Pasteur, a Sanofi Company

Completed

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

Virus Diseases | Bacterial Infections | Neisseria Meningitidis
Duke University
Centers for Disease Control and Prevention; Kaiser Permanente

Completed

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Fever | Febrile Seizure | Fever After Vaccination

United States
Baylor Research Institute

Terminated

Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer (PancVax)

Pancreatic Cancer

United States
Pfizer

Completed

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Vaccines | Meningococcal Vaccines

United States
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer

Prostate Cancer

Czechia
Istituto Scientifico Romagnolo per lo Studio e...

Withdrawn

Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC (RENALVax-2)

Carcinoma, Renal Cell | Secondary | Vaccination

Italy
Wayne State University
Merck Sharp & Dohme LLC

Completed

Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients (GARDASIL)

Systemic Lupus Erythematosus

United States
Novartis Vaccines

Completed

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

Meningococcal Meningitis

Canada
Pfizer

Completed

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

Pneumococcal Infections

United States
Kiromic, Inc.

Withdrawn

Therapy for Progressive and/or Refractory Hematologic Malignancies

Cancer | Hematologic Malignancies
University of Pittsburgh
Merck Sharp & Dohme LLC; Pfizer

Completed

4 Pillars Toolkit for Adolescent Vaccination

Adolescent HPV Vaccine | Adolescent Influenza Vaccine

United States
Kiromic, Inc.

Withdrawn

Consolidation Therapy in Patients With Metastatic Solid Malignancies

Cancer | Metastatic Solid Malignancies
GlaxoSmithKline

Completed

HerpeVac Trial for Young Women

Herpes Simplex Infection

United States, Canada
Precision Life Sciences Group

Completed

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Glioblastoma Multiforme

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC

Kidney Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Autologous OC-DC Vaccine in Ovarian Cancer

Ovarian Cancer | Chemotherapy | Tumor

United States
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

Tetanus | Diphtheria | Acellular Pertussis

Finland
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

Tetanus | Diphtheria | Acellular Pertussis

United States
Sichuan University

Unknown

Personalized DC Vaccine for Lung Cancer (SKLB1608)

Carcinoma, Non-Small-Cell Lung

China
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
Sanofi Pasteur, a Sanofi Company

Completed

Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age

Hepatitis B

Thailand
Dana-Farber Cancer Institute
Millennium Pharmaceuticals, Inc.

Completed

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Multiple Myeloma

United States
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Completed

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma (GeniusVac-Mel4)

Melanoma | Effects of Immunotherapy | Tumor Vaccines

France
Beth Israel Deaconess Medical Center
Harvard Medical School (HMS and HSDM); National Cancer Institute (NCI); Dana-Farber... and other collaborators

Terminated

Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12

Breast Cancer

United States
Emory University
International AIDS Vaccine Initiative; Zambia-Emory HIV Research Project

Completed

Zambia SiVET MMR Tdap-IPV (SiVET)

High Risk for HIV

Zambia
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

Sarcoma | Neuroblastoma | Wilm's Tumor

United States
Mendus
Uppsala University

Completed

Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Sweden
Pawel Kalinski
National Cancer Institute (NCI)

Completed

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults

Healthy

France, Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

Infections, Meningococcal

Germany, Korea, Republic of, Dominican Republic
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza (IRC002)

Influenza A | Influenza B

United States
Lisa H. Butterfield, Ph.D.
National Cancer Institute (NCI)

Completed

Multiple Antigen-Engineered DC Vaccine for Melanoma

Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Johns Hopkins All Children's Hospital

Withdrawn

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Neoplasms, Nerve Tissue | Neuroblastoma
John Kirkwood
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

Metastatic Melanoma

United States
BGI, China
Fujian Cancer Hospital

Unknown

TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor

Tumor Gastric | Tumor, Colorectal
University of Pennsylvania
Abramson Cancer Center of the University of Pennsylvania

No longer available

Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer

Metastatic Cancer

United States
McMaster University

Unknown

Homeopathic Vaccine Trial (HVT)

Healthy Volunteers

Canada
Genentech, Inc.

Completed

A Study of the Safety, Tolerability, Pharmacokinetics, and Bioavailability of IV and SC MABT5102A in Healthy Volunteers

Healthy Volunteer
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer

Prostate Cancer

Czechia
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic

Czechia
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Prostate Cancer

Czechia
University of Louisville
Merck Sharp & Dohme LLC

Completed

Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making

Cervical Cancer

United States
National Institute of Allergy and Infectious Diseases...

Completed

Tdap Vaccine in Post-Partum Women

Pertussis | Tetanus | Diphtheria

United States
Research Institute of Fundamental and Clinical...

Unknown

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer (BC-LDC)

Breast Cancer
Edward Hirschowitz
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

Lung Cancer

United States
Beth Israel Deaconess Medical Center
Genzyme, a Sanofi Company

Completed

The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma

Metastatic Melanoma

United States

Search clinical trials for: DC Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations